ACTRN12623001124628招募中Unknown
Evaluation of the impact and implementation of a service model (intervention) delivered by community pharmacists in NSW (and 15 pharmacies in ACT) re-supplying specific oral contraceptive pills to women aged 18 to 35: PATH-OC
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 88,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 35 Years（—）
- 性别
- Female
入选标准
- •Pharmacies and pharmacists recruited in NSW must meet the eligibility criteria (defined below) to participate in the study, reflecting the criteria set by the Authority under Section 10 Poisons and Therapeutic Good Act 1966 Clauses 170 and 171 of the Poisons and Therapeutic Goods Regulation 2008. Pharmacies and pharmacists recruited in ACT will be issued a discretionary licence to participate in the trial.
- •Community pharmacies
- •A community pharmacy in NSW or ACT must have a service room, consulting room, or area consistent with the following:
- •An ‘approved pharmacy’ means a pharmacy or class of pharmacies, approved in writing by the Chief Health Officer, which has a service room, consulting room, or area consistent with the following:
- •o the room or area is not to be used as a dispensary, storeroom, staff room or retail area,
- •o fully enclosed and provides adequate privacy (a divider or curtain in a dispensary, storeroom, staff room or retail area is not acceptable),
- •o has adequate lighting,
- •o is maintained at a comfortable ambient temperature,
- •o has a hand sanitisation facility,
- •o has ready access to a hand washing facility, and
- •o has sufficient floor area, clear of equipment and furniture, to accommodate the person receiving the consultation and an accompanying person, and to allow the pharmacist adequate space to manoeuvre.”
- •Pharmacies must have access to MedAdvisor to complete clinical record keeping for the purposes of the clinical trial assessment.
- •Pharmacists
- •The eligibility criteria for an approved pharmacist to participate in the study, which includes that the pharmacist must be:
- •employed or engaged in an ‘approved pharmacy’ who has successfully completed the following training:
- •Australasian College of Pharmacy Continuation of Oral Contraception Course; or
- •Pharmaceutical Society of Australia NSW – Contraception Essentials; and
- •A series of study training module(s) that have been approved by the Chief Health Officer for the purposes of the clinical trial.”
- •A pharmacist is eligible to participate if they hold general registration as a pharmacist with the Australian Health Practitioner Regulation Agency (AHPRA). Pharmacists with provisional registration (intern pharmacists) and pharmacists with conditions on their registration are not eligible to participate in the trial.
- •The pharmacy must have at least one eligible pharmacist who is willing to provide their voluntary consent to participate, for the pharmacy to be eligible, and that there is always a pharmacist available to deliver the service during all opening hours of the pharmacy.
- •Natal, cis females (capable of pregnancy).
- •Aged 18 years of age or over and up to and including aged 35 years.
- •Present to community pharmacies in NSW or pharmacies in ACT to obtain a continuing supply of their previously prescribed oral contraceptive pill.
- •Patient has been initiated on an oral contraceptive pill by their GP (or other authorised prescribing health care professional) primarily for the indication of contraception and has been stabilised on that pill for 2 years continuously.
- •Patient is taking an approved oral contraceptive pill listed in the NSW Health Authority.
- •Patient has seen their GP (or other authorised prescribing health care professional) for a review of their oral contraceptive pill in the last 2 years.
排除标准
- •Individuals who are not female.
- •Aged <18 years or >35 years.
- •Patient has not been initiated on an oral contraceptive pill by their GP (or other authorised prescribing health care professional).
- •Patient is not taking an approved oral contraceptive pill listed in the NSW Health Authority.
- •Patient has not seen their GP (or other authorised prescribing health care professional) for a review of their oral contraceptive pill in the last 2 years.
研究者
相似试验
招募中
不适用
Investigation of the implementation and efficacy of a new standard operating procedure (SOP) concerning the prevention of post-operative nausea and vomiting (PONV)post-operative nausea and vomitingDRKS00030713niversitätsklinikum Essen, Klinik für Anästhesiologie und Intensivmedizin2,000
已完成
不适用
Effect of an intervention based on the planned behavior model on the health promoting behavior’s intention of carpet weaver womeHealth promoting behaviors.Problems related to lifestyleIRCT2016081314333N55Vice chancellor for research, Kermanshah University of Medical Sciences60
已完成
不适用
Implementation and Evaluation the Effectiveness of Health care Volunteers EducatioEfficacy of a health volunteers program based on Kerkpatrick modela.Problems related to education and literacyIRCT20140503017546N12Shiraz University of Medical Sciences110
尚未招募
Unknown
Implementation of a supportive care navigation tool for people diagnosed with pancreatic cancerpancreatic cancerACTRN12624001067561Flinders Medical Centre95
已完成
不适用
Effectiveness of Implementation Discharge Planning Program on Quality of LifeBreast Cancer.Malignant Neoplasm of BreastIRCT201101105580N1Vice chancellor for research, Tehran university of medical sciences69